https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.935553/full
Frontiers | Argininosuccinate synthase 1, arginine deprivation therapy and cancer management
Metabolic reprogramming is an emerging hallmark of tumor cells. In order to survive in nutrient-deprived environment, tumor cells rewire their metabolic phen...
argininosuccinate synthase1 argininefrontiersdeprivationtherapy